Nancy A. Melville PHOENIX — Subcutaneous efgartigimod PH20 SC shows efficacy and tolerability in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), providing a convenient alternative to intravenous and other older treatments for this rare disease. “This was the largest study of CIDP that has been performed, with over 600 patients screened and 322 enrolled,...
Month: <span>November 2023</span>
Post
Genetic Therapies Bring Change to Neurology Clinics
Jim Kling PHOENIX – New therapies are on the horizon for genetic neuromuscular diseases, and this will raise both hopes for patients and challenges for neurologists. Following successful genetic treatments for ALS, hereditary amyloidosis, and spinal muscular atrophy, therapies for conditions like Charcot-Marie-Tooth (CMT) neuropathy are set to change neurology practice, according to Nicolas Madigan,...
Post
5 Ways You Can Use AI In Your Healthcare RIGHT NOW
Let’s see five areas where AI can be used for personal health management.Andrea KonczKey Takeaways Despite the continuous buzz surrounding AI over the past year, many individuals remain unaware of how to utilize AI for their personal health management. Various use cases are emerging, ranging from skin-checking apps and specialized health chatbots to employing generative...
Post
Breathalyzers, Breathomics And Exhalomics In The Digital Health Age
Digital health tech revolutionizes respiratory care, from personal breathalyzers to breathomics, offering non-invasive diagnostics and monitoring. Pranavsingh DhunnooKey Takeaways The field of breathomics, which studies volatile compounds in exhaled breath, offers a non-invasive method for diagnosing respiratory illnesses, with potential for such analysis to become a standard assessment during medical visits. Respiratory diseases are predicted...
Post
Renal Cell Carcinoma: 5 Things to Know for Primary Care
Karl J. D’Silva, MDDISCLOSURES Renal cell carcinoma (RCC) represents up to 85% of kidney cancers. It is considered the deadliest urologic cancer in the United States, with a 5-year survival rate of 76% overall, going down to only 12% for patients with late-stage disease. Here are five things that primary care clinicians should know about...
Post
Portable device detects Alzheimer’s and Parkinson’s biomarkers on the spot
By Ben Coxworth The prototype device, which is currently being commercialized by biotech company Ampera LifeDavid Baillot/UC San Diego Jacobs School of Engineering Because of the logistics and invasive procedures involved, many people put off getting tested for Alzheimer’s and Parkinson’s diseases. Thanks to a new portable device, however, such testing could soon be performed non-invasively...
Post
Protein discovery raises prospect of treatment for COPD
By Paul McClure Researchers have discovered a protein associated with antiviral defense can exacerbate COPDDepositphotos A new study has found that TLR7, a protein that normally triggers our immune system to defend against certain viruses, plays a pivotal role in exacerbating chronic obstructive pulmonary disease or COPD. The unexpected discovery may lead to new therapeutic approaches...
Post
Apple Cider Vinegar Benefits: What the Science Says
Written by Christina Palmer, MD | Reviewed by Patricia Pinto-Garcia, MD, MPH Key takeaways: Michelle Lee Photography/iStock via Getty Images Apple cider vinegar seems to be everywhere these days — from drinks and dressings to gummies. But what is it, why are people buying it, and should you be consuming it? Apple cider vinegar is...
Post
Colleges face gambling addiction among students as sports betting spreads
by Jason W. Osborne, The Conversation Credit: Pixabay/CC0 Public Domain Three out of four college students have gambled in the past year, whether legally or illegally, according to the National Council on Problem Gambling. An estimated 2% to 3% of U.S. adults have a gambling problem. The portion of college students with a problem, however, is...
Post
New research advances understanding of cancer risk in gene therapies
by University of York Landscape of somatic mutations in SCD. a, Dot-plot showing the number of mutations per HSPC for each patient plotted against the patient age at the time of sampling. SNV mutation burdens of individual HSPC colonies from before GT, with correction for coverage, are displayed per patient. Mean mutation burdens per individual are...